Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

Read more about Deep reinforcement learning could redefine insulin delivery for diabetes patients on Devdiscourse ...

Medtronic has submitted 510(k) applications to the U.S. Food and Drug Administration seeking clearance for an interoperable pump.

Medtronic (NYSE:MDT) announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable ...

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

The infusion pumps market is experiencing significant growth due to the increasing demand for advanced healthcare solutions, particularly in the management of chronic diseases and critical care.

Unlike type 1, type 2 diabetes can sometimes be prevented. According to the charity Diabetes UK, research has shown for some ...

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...

Glucotrack (GCTK) will participate in the FORGETDIABETES bionic pancreas initiative that will develop a long-term, automated insulin delivery ...

The Global Insulin Pump Market achieved a valuation of $5.90 Billion in 2024 and is anticipated to exceed $14.49 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 8.55% during the ...

Beck and colleagues from the JAEB Center for Health Research, Tampa, Florida, USA, highlight the rapid onset of action of inhaled Technosphere Insulin (TI, Afrezza) compare ...

Revolutionizing diabetes care with AI-driven, personalized treatment solutions. Explore key trends, market growth, and leading players shaping the future from 2025 to 2035 ...